EUVIMEDEUVIMED entdecken
Crossref

Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret

Dongyang Hong, Zhilei Zhang, Yun Sun, Xin Wang, Peiying Yang, Tao Jiang, Bin Yu iD

Laboratory Medicine · 2025

DOI: 10.1093/labmed/lmae127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2025. Verfasst von Dongyang Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Medicine Center, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, Ch…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Proto-Oncogene Proteins c-ret. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nanjing Health Science and Technology Development Special Fund, Clinical frontier technology of Changzhou Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting 5% to 19% of carriers. Creatine kinase (CK) is a traditional biomarker for DMD, but its screening accuracy is limited. This study evaluated the potential of combining the proto-oncogene tyrosine-protein kinase receptor Ret (RET) with CK-MM to enhance screening efficacy.

Methods

Creatine kinase-MM and RET levels were analyzed in 14 adult and 5 newborn carriers of DMD, along with noncarrier control individuals. The CK-MM/RET ratio was calculated, and a receiver operating characteristic curve analysis evaluated biomarker screening efficiency. Methods for extracting RET from dried blood spots (DBSs) were compared with correlations between DBSs and serum RET levels and stability under varying storage conditions.

Results

Carriers of DMD exhibited elevated CK-MM and CK-MM/RET ratios with reduced RET. The CK-MM/RET ratio had the highest screening efficiency. Extraction of RET was optimal using Diluent C at 4 °C overnight, showing a strong DBS-serum correlation; RET remained stable, except under high humidity and temperature conditions.

Discussion

Combining RET with CK-MM enhances DMD carrier screening, offering a more efficient DBS-based method for early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneProto-Oncogene Proteins c-retHumansProto-Oncogene MasAdultMaleInfant, NewbornDried Blood Spot TestingCreatine KinaseBiomarkersFemaleYoung Adult

Stichwörter der Autor:innen

Duchenne muscular dystrophyRETcarriercreatine kinase-MMdried blood spotproto-oncogene tyrosine-protein kinase receptor Ret

Substanzen

Proto-Oncogene MasMAS1 protein, humanProto-Oncogene Proteins c-retRET protein, humanCreatine KinaseBiomarkers

Autor:innen und Institutionen

  • Department of Genetic Medicine Center, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing, China.
  • Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center of Nanjing Medical University, Changzhou, China.

ORCID-Profile: Bin Yu

Förderung

  • National Natural Science Foundation of China
  • Nanjing Health Science and Technology Development Special Fund
  • Clinical frontier technology of Changzhou Health Commission

Zitieren

APA

Hong, D., Zhang, Z., Sun, Y., Wang, X., Yang, P., Jiang, T., & Yu, B. (2025). Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret. Laboratory Medicine. https://doi.org/10.1093/labmed/lmae127

Vancouver

Hong D, Zhang Z, Sun Y, Wang X, Yang P, Jiang T, et al. Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret. Laboratory Medicine. 2025. doi:10.1093/labmed/lmae127

BibTeX
@article{Hong2025,
  author = {Hong, Dongyang and Zhang, Zhilei and Sun, Yun and Wang, Xin and Yang, Peiying and Jiang, Tao and Yu, Bin},
  title = {Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret},
  journal = {Laboratory Medicine},
  year = {2025},
  doi = {10.1093/labmed/lmae127}
}
Kostenlos starten →